Antifungal repurposing of clinical chelator DMSA against Cryptococcus neoformans via laccase and histidine biosynthesis inhibition
Microbial Pathogenesis · 2026
DOI: 10.1016/j.micpath.2026.108375 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Pathogenesis, 2026. Verfasst von Chen Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Cryptococcus neoformans, Laccase, Antifungal Agents, Chelating Agents. Die Arbeit nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, School of Chemistry, Sun Yat-Sen University, Guangzhou, 510275, China.
- State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, 210023, China.
- Jinling Clinical Medical College, Nanjing Medical University, China.
- Department of Dermatology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Electronic address: sanghong@nju.edu.cn.
- Department of Dermatology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Electronic address: kongqingtao2008@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, C., Peng, M., Hu, Q., Huang, S., Zhang, Q., Zhu, J., Sang, H., & Kong, Q. (2026). Antifungal repurposing of clinical chelator DMSA against Cryptococcus neoformans via laccase and histidine biosynthesis inhibition. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2026.108375
Vancouver
Zhang C, Peng M, Hu Q, Huang S, Zhang Q, Zhu J, et al. Antifungal repurposing of clinical chelator DMSA against Cryptococcus neoformans via laccase and histidine biosynthesis inhibition. Microbial Pathogenesis. 2026. doi:10.1016/j.micpath.2026.108375
BibTeX
@article{Zhang2026,
author = {Zhang, Chen and Peng, Min and Hu, Qingyuan and Huang, Shanqing and Zhang, Qi and Zhu, Jiang and Sang, Hong and Kong, Qingtao},
title = {Antifungal repurposing of clinical chelator DMSA against Cryptococcus neoformans via laccase and histidine biosynthesis inhibition},
journal = {Microbial Pathogenesis},
year = {2026},
doi = {10.1016/j.micpath.2026.108375}
}
EUVIMED